ArticlePharmaceuticals (Basel, Switzerland)2025

Purine-Hydrazone Scaffolds as Potential Dual EGFR/HER2 Inhibitors.

Fatemah S Albalawi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.